Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03922815
Other study ID # SilesianMUKOAiIT12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date January 31, 2020

Study information

Verified date October 2018
Source Medical University of Silesia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized prospective trial is to assess the utility of Adequacy of Anaesthesia technique (Response Entropy and Surgical Pleth Index) for monitoring pain perception intraoperatively and its influence on postoperative pain perception, both patients' and operators' satisfaction in patients undergoing colonoscopic procedures under intravenous sedation using propofol and fentanyl.


Description:

Surgical Pleth Index (SPI) is reported to properly reflect nociception-antinociception balance in patients undergoing surgical procedures, where a value of 100 corresponds to a high stress level and a value of 0 to a low stress level; values near 50 or increase in value > delta 10 correspond to the stress level which is known to reflect requirement for rescue analgesia. The applicability of SPI- guided deep sedation regimen in colonoscopic procedures has not been previously studied. Additionally, depth of sedation markedly influences the nociception-antinociception balance so its monitoring also proved useful in procedures performed under deep sedation. Therefore, we aim to investigate if both SPI-guided fentanyl administration alongside with State Entropy guided propofol aministration (Adequacy of Anaesthesia monitoring) versus State Entropy guided propofol aministration alongside with fentanyl titration based on haemodynamic parametres versus fentanyl titration based on haemodynamic parametres only influence both patients' or operator's satisfaction from anaesthetic management.


Recruitment information / eligibility

Status Completed
Enrollment 158
Est. completion date January 31, 2020
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - written consent to participate in the study - written consent to undergo deep sedation for colonoscopic procedure - general heath condition I-III of American Society of Anaesthesiology Exclusion Criteria: - necessity of administration of vasoactive drugs influencing SPI monitoring - pregnancy - anatomical malformation that make monitoring using SE sensor impossible - general atherosclerosis, heart rhythm disturbances impairing SPI monitoring - chronic medication using opioid drugs leading to resistancy to opioids.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
rescue fentanyl
a rescue dose of fentanyl 0,5 mcg per kilogram of body
rescue propofol
propofol in a single dose of 0,5 mg/kg of body weight

Locations

Country Name City State
Poland Medical University of Silesia Sosnowiec Silesia

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Silesia

Country where clinical trial is conducted

Poland, 

References & Publications (7)

Abu Baker F, Mari A, Aamarney K, Hakeem AR, Ovadia B, Kopelman Y. Propofol sedation in colonoscopy: from satisfied patients to improved quality indicators. Clin Exp Gastroenterol. 2019 Feb 26;12:105-110. doi: 10.2147/CEG.S186393. eCollection 2019. — View Citation

Gruenewald M, Herz J, Schoenherr T, Thee C, Steinfath M, Bein B. Measurement of the nociceptive balance by Analgesia Nociception Index and Surgical Pleth Index during sevoflurane-remifentanil anesthesia. Minerva Anestesiol. 2015 May;81(5):480-9. Epub 2014 — View Citation

Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Höcker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. — View Citation

Gruenewald M, Ilies C. Monitoring the nociception-anti-nociception balance. Best Pract Res Clin Anaesthesiol. 2013 Jun;27(2):235-47. doi: 10.1016/j.bpa.2013.06.007. Review. — View Citation

Gruenewald M, Willms S, Broch O, Kott M, Steinfath M, Bein B. Sufentanil administration guided by surgical pleth index vs standard practice during sevoflurane anaesthesia: a randomized controlled pilot study. Br J Anaesth. 2014 May;112(5):898-905. doi: 10 — View Citation

Won YJ, Lim BG, Lee SH, Park S, Kim H, Lee IO, Kong MH. Comparison of relative oxycodone consumption in surgical pleth index-guided analgesia versus conventional analgesia during sevoflurane anesthesia: A randomized controlled trial. Medicine (Baltimore). — View Citation

Zhang W, Zhu Z, Zheng Y. Effect and safety of propofol for sedation during colonoscopy: A meta-analysis. J Clin Anesth. 2018 Dec;51:10-18. doi: 10.1016/j.jclinane.2018.07.005. Epub 2018 Jul 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary intraoperative pain perception: 11 points numeric rating scale the patient will be asked if he/she had any reminiscence of pain perception during procedure of colonoscopy using 11 points numeric rating scale (0 - no pain, 10 - maximum pain) after 2 hours after emergence from sedation
Primary postoperative pain perception: 11 points numeric rating scale the patient will be asked if he/she had any pain perception after emergence from sedation after procedure of colonoscopy using 11 points numeric rating scale (0 - no pain, 10 - maximum pain) immediately after emergence form sedation
Secondary patient's satisfaction: 4 points numeric rating scale the patient will be asked if he/she was satisfied with sedation quality for the procedure of colonoscopy using 4 points numeric scale 2 hours after emergence from sedation
Secondary operator's satisfaction: 4 points numeric scale the operator will be asked if he/she was satisfied with sedation quality for the procedure of colonoscopy using 4 points numeric scale immediately after the end of the procedure
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00153751 - The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS) Phase 2
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Completed NCT01176227 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) Phase 1/Phase 2
Completed NCT01887834 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome Phase 1/Phase 2
Completed NCT00130741 - Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) Phase 1
Completed NCT01072903 - The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS) N/A
Active, not recruiting NCT01028898 - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome N/A
Recruiting NCT03854422 - For Easy, Fast and Comfortable Colonoscopy, Which Position N/A
Completed NCT02551029 - fMRI and Visceral Perception Upon Capsaicin Infusion N/A
Completed NCT02716285 - Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery Phase 3
Completed NCT05340400 - The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
Completed NCT00189033 - Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? N/A